PHV-wordings
NSAID-containing medicinal products (for systemic use)
Additional template
|
09/09/2022
Further information is available in the CMDh press release (Report from the meeting held on 13-14 September 2022 and Report from the meeting held on 19-20 July 2022) on the HMA-Website.
NSAIDs Ibuprofen (for systemic use)
Additional template
|
26/08/2022
Further information is available in the CMDh press release (Report from the meeting held on 19-20 July 2022) on the HMA-Website.
Dexketoprofen
PSUR-outcome
|
16/08/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Soybean phospholipids (oral use)
PSUR-outcome
|
16/08/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Diclofenac systemisch
PSUR-outcome
|
11/08/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Teicoplanin
PSUR-outcome
|
08/08/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Methylphenidate
PSUR-outcome
|
08/08/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Rabeprazole
PSUR-outcome
|
08/08/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Alfentanil
PSUR-outcome
|
05/07/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Brinzolamide
PSUR-outcome
|
05/07/2022
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
